Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (MTG49)
Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia
Search results
45 results for bph
-
-
Northampton General Day Case BPH service evaluation – adoption of Urolift
patients as alternative to TURP for troublesome symptoms of Benign Prostate Hyperplasia (BPH) would result in cost and...
-
Shared Learning Awards 2020 highly commended example - Northampton General Day Case benign prostatic hyperplasia service evaluation
Shared Learning Awards 2020 highly commended example - Northampton General Day Case benign prostatic hyperplasia service evaluation
-
GID-MT564 GreenLight XPS for treating benign prostatic hyperplasia
In development [GID-MT564] Expected publication date: 14 October 2022
-
GreenLight XPS for treating benign prostatic hyperplasia (MTG29)
Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia
-
Insights from the NHS: adoption of UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia at Frimley Park Hospital
for use in a day case setting in men with lower urinary tract symptoms of BPH. This case study has been adapted from the 'NICE medical...
-
Insights from the NHS: adoption of UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia at St Helens and Knowsley Teaching Hospital NHS Trust
sexual function that can happen as a result of treatment for benign prostatic hyperplasia (BPH), the Urology team at the...
-
Adoption of UroLift procedure, an ambulatory pathway for patients suffering from Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia
November 2016 Benign Prostate Hyperplasia (BPH) is a long-term and progressive condition, resulting in lower
-
Treating Benign Prostatic Obstruction (BPO) with UroLift in an outpatient setting
pathway, improve efficiency and maintain quality of care for men in Fife with BPH. Performing Urolift in an outpatient setting in the...
-
Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal) (TA273)
NICE is unable to make a recommendation about the use in the NHS of tadalafil for treating symptoms associated with benign prostatic hyperplasia...
-
Urolift – a community-based alternative treatment for Benign Prostatic Obstruction (BPO)
lower urinary tract symptoms of benign prostatic hyperplasia. BPO describes the cause of lower urinary tract symptoms from...
-
Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia
In development [GID-IPG10214] Expected publication date: 21 September 2022
-
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG58)
Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia
-
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG611)
Evidence-based recommendations on prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults
-
Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG629)
Evidence-based recommendations on transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults